Advanced search
Add to list

Clinical performance of an epigenetic assay to identify occult high-grade prostate cancer in African American men

(2017) JOURNAL OF UROLOGY. 197(4, suppl.). p.E128-E128
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Van Neste, Leander, et al. “Clinical Performance of an Epigenetic Assay to Identify Occult High-Grade Prostate Cancer in African American Men.” JOURNAL OF UROLOGY, vol. 197, no. 4, suppl., 2017, pp. E128–E128, doi:10.1016/j.juro.2017.02.379.
APA
Van Neste, L., Barnswell, C., Jalkut, M., Tutrone, R., Sylora, J., Anglade, R., … Waterhouse, R. (2017). Clinical performance of an epigenetic assay to identify occult high-grade prostate cancer in African American men. In JOURNAL OF UROLOGY (Vol. 197, pp. E128–E128). Boston, MA, USA. https://doi.org/10.1016/j.juro.2017.02.379
Chicago author-date
Van Neste, Leander, Carlton Barnswell, Mark Jalkut, Ronald Tutrone, James Sylora, Ronald Anglade, Myron Murdock, et al. 2017. “Clinical Performance of an Epigenetic Assay to Identify Occult High-Grade Prostate Cancer in African American Men.” In JOURNAL OF UROLOGY, 197:E128–E128. https://doi.org/10.1016/j.juro.2017.02.379.
Chicago author-date (all authors)
Van Neste, Leander, Carlton Barnswell, Mark Jalkut, Ronald Tutrone, James Sylora, Ronald Anglade, Myron Murdock, Kelvin A Moses, Zvi Shiffman, Todd Vandenberg, Nikhil Shah, Jonathon Silberstein, Jack Groskopf, Wim Van Criekinge, and Robert Waterhouse. 2017. “Clinical Performance of an Epigenetic Assay to Identify Occult High-Grade Prostate Cancer in African American Men.” In JOURNAL OF UROLOGY, 197:E128–E128. doi:10.1016/j.juro.2017.02.379.
Vancouver
1.
Van Neste L, Barnswell C, Jalkut M, Tutrone R, Sylora J, Anglade R, et al. Clinical performance of an epigenetic assay to identify occult high-grade prostate cancer in African American men. In: JOURNAL OF UROLOGY. 2017. p. E128–E128.
IEEE
[1]
L. Van Neste et al., “Clinical performance of an epigenetic assay to identify occult high-grade prostate cancer in African American men,” in JOURNAL OF UROLOGY, Boston, MA, USA, 2017, vol. 197, no. 4, suppl., pp. E128–E128.
@inproceedings{8557771,
  articleno    = {{abstract PD07-04}},
  author       = {{Van Neste, Leander and Barnswell, Carlton and Jalkut, Mark and Tutrone, Ronald and Sylora, James and Anglade, Ronald and Murdock, Myron and Moses, Kelvin A and Shiffman, Zvi and Vandenberg, Todd and Shah, Nikhil and Silberstein, Jonathon and Groskopf, Jack and Van Criekinge, Wim and Waterhouse, Robert}},
  booktitle    = {{JOURNAL OF UROLOGY}},
  issn         = {{0022-5347}},
  language     = {{eng}},
  location     = {{Boston, MA, USA}},
  number       = {{4, suppl.}},
  pages        = {{abstract PD07-04:E128--abstract PD07-04:E128}},
  title        = {{Clinical performance of an epigenetic assay to identify occult high-grade prostate cancer in African American men}},
  url          = {{http://dx.doi.org/10.1016/j.juro.2017.02.379}},
  volume       = {{197}},
  year         = {{2017}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: